10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001104659-21-062387`
Period End Date	20210331
Filing Date	20210506
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	cldx-20210331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 26 Cash Flow Statement 45

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$43.84M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.31M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.72M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$150.59M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$106.77M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.83M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.80M	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.59M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.62M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	39.60M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$181.50M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	39.61M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$197.84M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	39.61M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	39.60M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.75M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.81M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.09M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.45M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.69M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Total assets	`Assets`	$235.84M	USD	Point-in-time
Total assets	`Assets`	$219.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$997.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.46M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.02M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.37M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.33M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$3.37M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$7.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.98M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.21M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.15M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.76M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.16M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$24.90M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.48M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at March 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at March 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 39,614,638 and 39,603,771 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 39,614,638 and 39,603,771 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.28B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.28B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.07B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.09B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$83.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$209.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$94.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$194.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$235.84M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$219.06M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$685.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.73M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$12.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$11.70M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.12M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.67M	USD	1 Quarter
Loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-234.00K	USD	1 Quarter
Loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-483.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$17.32M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$15.60M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-12.87M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-16.64M	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$242.00K	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$101.00K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.42	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.41M	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.61M	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-22.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.54M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-12.65M	USD	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$775.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.17M	USD	1 Quarter
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$63.00K	USD	1 Quarter
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$48.00K	USD	1 Quarter
Gain on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$24.00K	USD	1 Quarter
Loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-234.00K	USD	1 Quarter
Loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-483.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$687.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.27M	USD	1 Quarter
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$93.00K	USD	1 Quarter
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$26.00K	USD	1 Quarter
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-206.00K	USD	1 Quarter
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.14M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-853.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.27M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-578.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-768.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.11M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.08M	USD	1 Quarter
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.20M	USD	1 Quarter
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$78.00M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$33.97M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$235.00K	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$567.00K	USD	1 Quarter
Proceeds from sale or disposal of assets	`ProceedsFromSaleOfProductiveAssets`	$24.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$21.96M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$43.49M	USD	1 Quarter
Net proceeds from stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.61M	USD	1 Quarter
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$24.00K	USD	1 Quarter
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$74.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$74.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.64M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$25.48M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.49M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$43.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$69.31M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$22.72M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$43.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$69.31M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$22.72M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$462.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.